https://en4inhibitor.com/tradi....tional-management-of
When comparing PGEG and PGDT quality of life (QOL), the breakdown according to remnant stomach sizes (1/2 and 2/3) revealed that PGDT demonstrated a superior performance compared to PGEG across various outcome measures (MOMs). Upon comparing the quality of life (QOL) metrics for PGEG and PGDT, a stratified analysis based on remnant stomach sizes of 1/2 and 2/3 demonstrated PGDT's relative superiority over PGEG for various months after operation (MOMs). W